Histone Deacetylase 3 Inhibition Ameliorates Microglia-Mediated Neuro-Inflammation Via the SIRT1/Nrf2 Pathway After Traumatic Spinal Cord Injury.

Abstract

BACKGROUND:

Microglial-induced inflammation plays a crucial role in the pathophysiological process of nervous system injury, however, still lacks effective therapeutic agents. Previously, we discovered that the inhibition of histone deacetylase 3 (HDAC3) exerts anti-inflammatory effects after traumatic spinal cord injury (SCI), whereas little is known about its underlying mechanism. Therefore, the present study aimed to explore the effects and potential mechanisms of HDAC3 on neuroinflammation and microglial function.

METHODS:

Rats were randomized into 4 groups: sham group, SCI group, SCI + vehicle group, and SCI + RGF966 group. To examine the effect of HDAC3 on neurological deficit after SCI, we gathered data using the Basso Beattie Bresnahan locomotion scale, the inclined plane test, the blood-spinal cord barrier, junction protein expression, and Nissl staining. We also evaluated microglial activation and inflammatory factor levels. Immunofluorescence analysis, immunohistochemical analysis, western blotting, and quantitative real-time polymerase chain reaction were performed to examine the regulation of the Sirtuin 1 (SIRT1)/nuclear factor-erythroid 2-related factor 2 (Nrf2) pathway.

RESULTS:

The results showed that HDAC3 inhibition significantly ameliorated Basso-Beattie-Bresnahan (BBB) permeability, brain edema, and improved neurological functions and junction protein levels. Additionally, HDAC3 inhibition significantly inhibited microglial activation, thereby reducing the levels of SCI-induced pro-inflammatory factors. Moreover, HDAC3 inhibition dramatically enhanced the expression of SIRT1 and increased both Nrf2 nuclear accumulation and transcriptional activity, thereby increasing downstream heme oxygenase-1 and NAD(P)H quinone oxidoreductase 1 expression.

CONCLUSIONS:

The results of this study suggest that HDAC3 inhibition protects the spinal cord from injury following SCI by inhibiting SCI-induced microglial activation and the subsequent inflammatory response via SIRT1/Nrf2 signaling pathway, highlighting HDAC3 as a potential therapeutic target for the treatment of SCI.

• Authors: Shoubo Chen, Jingfang Ye, Guozhong Wu, Jinnan Shi, Xiang Li, Xiangrong Chen, Wenhua Wu
• Journal: Neurorehabilitation and neural repair (Neurorehabil Neural Repair) Vol. 37 Issue 8 Pg. 503-518 (08 2023) ISSN: 1552-6844 [Electronic] United States
• PMID: 37503724 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• histone deacetylase 3
• NF-E2-Related Factor 2
• Sirtuin 1
• Histone Deacetylase Inhibitors

Topics

• Animals
• Rats
• Inflammation (drug therapy, metabolism)
• Microglia (metabolism)
• NF-E2-Related Factor 2
• Rats, Sprague-Dawley
• Sirtuin 1 (metabolism)
• Spinal Cord
• Spinal Cord Injuries (complications, drug therapy, metabolism)
• Histone Deacetylase Inhibitors (pharmacology)